@article{article, title  = {{Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 url = {{http://eprints.whiterose.ac.uk/121723/ }},

 year = {{2017}},

 month = {{9}},

 author = {{Bermejo I and Stevenson M and Cooper K and Harnan S and Hamilton J and Clowes M and Carroll C and Harrison T and Saha S}},

 doi = {{10.1007/s40273-017-0571-8}},

 journal = {{Pharmacoeconomics}},

 note = {{Accessed on 2024/12/21}}}